Cited by 138Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression

Open access

Di Donna, P., Olivotto, I., Delcre, S. D. L., Caponi, D., Scaglione, M., Nault, I., Montefusco, A., Girolami, F., Cecchi, F., Haissaguerre, M., Gaita, F.·2010·Europace

DOI 10.1093/europace/euq013

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: In patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF), radiofrequency catheter ablation (RFCA) represents a promising option. However, the predictors of RFCA efficacy remain largely unknown. We assessed the outcome of a multicentre HCM cohort following RFCA for symptomatic AF refractory to medical therapy. METHODS AND RESULTS: Sixty-one patients (age 54 +/- 13 years; time from AF onset 5.7 +/- 5.5 years) with paroxysmal (n = 35; 57%), recent persistent (n = 15; 25%), or long-standing persistent AF (n = 11; 18%) were enrolled. A scheme with pulmonary vein isolation plus linear lesions was employed. Of the 61 patients, 32 (52%) required redo procedures. Antiarrhythmic therapy was maintained in 22 (54%). At the end of a 29 +/- 16 months follow-up, 41 patients (67%) were in sinus rhythm, including 17 of the 19 patients aged < or = 50 years, with marked improvement in New York Heart Association (NYHA) functional class (1.2 +/- 0.5 vs. 1.9 +/- 0.7 at baseline; P < 0.001). In the remaining 20 patients (33%), with AF recurrence, there was less marked, but still significant, improvement following RFCA (NYHA class 1.8 +/- 0.7 vs. 2.3 +/- 0.7 at baseline; P = 0.002). Independent predictors of AF recurrence were increased left atrium volume [hazard ratio (HR) per unit increase 1.009, 95% confidence interval (CI) 1.001-1.018; P = 0.037] and NYHA functional class (HR 2.24, 95% CI 1.16-4.35; P = 0.016). Among 11 genotyped HCM patients (6 with MYBPC3, 2 with MYH7, 1 with MYL2 and 2 with multiple mutations), RFCA success rate was comparable with that of the overall cohort (n = 8; 73%). CONCLUSION: RFCA was successful in restoring long-term sinus rhythm and improving symptomatic status in most HCM patients with refractory AF, including the subset with proven sarcomere gene mutations, although redo procedures were often necessary. Younger HCM patients with small atrial size and mild symptoms proved to be the best RFCA candidates, likely due to lesser degrees of atrial remodelling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/europace/euq013

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citation
Catheter Ablation for Paroxysmal Atrial Fibrillation
Oral, H., Scharf, C., Chugh, A., HALL, B. W., Cheung, P. W., Good, E. D., Veerareddy, S., Pelosi, F., & Morady, F. (2003) · Circulation · doi:10.1161/01.cir.0000095796.45180.88 · Cited by 896
Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation
Pappone, C., Oreto, G., Rosanio, S., Vicedomini, G., Tocchi, M., Gugliotta, F., Salvati, A., DICANDIA, C. D., Calabrò, M. P., Mazzone, P., et al. (2001) · Circulation · doi:10.1161/hc4601.098517 · Cited by 855
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Self-citation
Pathophysiology and Prevention of Atrial Fibrillation
Allessie, M. A., Boyden, P. A., Camm, A. J., Kléber, A. G., Lab, M. J., Legato, M. J., Rosen, M. R., Schwartz, P. J., Spooner, P. M., Wagoner, D. R. V., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.769 · Cited by 724
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 653
Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort
Maron, B. J. (1999) · JAMA · doi:10.1001/jama.281.7.650 · Cited by 553

Show all 28 references

Sorted by citations

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citation
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citation
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 825
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Self-citation
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.021 · Cited by 581
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review
Guttmann, O. P., Rahman, M. S., O’Mahony, C., Anastasakis, A., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-304276 · Cited by 357
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352
Self-citation
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 342
Self-citation
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 326
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Rowin, E. J., Hausvater, A., Link, M. S., Abt, P., Gionfriddo, W., Wang, W., Rastegar, H., Estes, N. A. M., Maron, M. S., & Maron, B. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029267 · Cited by 262
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
Linhart, A., Germain, D. P., Olivotto, I., Akhtar, M. M., Anastasakis, A., Hughes, D. A., Namdar, M., Pieroni, M., Hagège, A. A., Cecchi, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1960 · Cited by 233
Self-citation
Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis
D’Ascenzo, F., Corleto, A., Biondi‐Zoccai, G., Anselmino, M., Ferraris, F., Biase, L. D., Natale, A., Hunter, R. J., SCHILLING, R. J., Miyazaki, S., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.008 · Cited by 216
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
Spoladore, R., Maron, M. S., D’Amato, R., Camici, P. G., & Olivotto, I. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs150 · Cited by 181
Self-citation
Pharmacological Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
Ammirati, E., Contri, R., Coppini, R., Cecchi, F., Frigerio, M., & Olivotto, I. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.541 · Cited by 148
Self-citation
Management of Atrial Fibrillation in Patients With Structural Heart Disease
Darby, A. E., & Dimarco, J. (2012) · Circulation · doi:10.1161/circulationaha.111.019935 · Cited by 141
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Providencia, R., Elliott, P., Patel, K., McCready, J., Babu, G., Srinivasan, N., Bronis, K., Papageorgiou, N., Chow, A., Rowland, E., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309406 · Cited by 122
Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation
McCready, J. W., Smedley, T., Lambiase, P. D., Ahsan, S., Segal, O. R., Rowland, E., LOWE, M. D., & CHOW, A. W. C. (2010) · EP Europace · doi:10.1093/europace/euq434 · Cited by 128
Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Santangeli, P., Biase, L. D., Themistoclakis, S., Raviele, A., Schweikert, R. A., Lakkireddy, D., Mohanty, P. K., Bai, R., Mohanty, S., Pump, A., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000339 · Cited by 110
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
Vriesendorp, P. A., Schinkel, A. F. L., Cleemput, J. V., Willems, R., Jordaens, L. J. L. M., Theuns, D. A. M. J., van Slegtenhorst, M. A., de Ravel, T. J. L., ten Cate, F. J., & Michels, M. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.009 · Cited by 105
Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
Zhao, D.-S., Shen, Y., Zhang, Q., Lin, G., Lu, Y.-H., Chen, B.-T., Shi, L.-S., Huang, J.-F., & Lu, H.-H. (2015) · EP Europace · doi:10.1093/europace/euv339 · Cited by 85
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.019 · Cited by 85
Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment
Makavos, G., Κairis, C., Tselegkidi, M.-E., Karamitsos, T. D., Rigopoulos, A. G., Noutsias, M., & Ikonomidis, I. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09775-4 · Cited by 86
MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside
Bogaert, J. G., & Olivotto, I. (2014) · Radiology · doi:10.1148/radiol.14131626 · Cited by 78
Self-citation
Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management
Garg, L., Gupta, M., Sabzwari, S. R. A., Agrawal, S., Agarwal, M. A., Nazir, T. F., Gordon, J. P., Bozorgnia, B., & Martinez, M. W. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9752-6 · Cited by 78
Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Macintyre, C. J., & Lakdawala, N. K. (2016) · Circulation · doi:10.1161/circulationaha.115.015085 · Cited by 73
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management
Ali, A. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1556 · Cited by 62
Left atrial structure and function predictors of recurrent fibrillation after catheter ablation: a systematic review and meta‐analysis
Bajraktari, G., Bytyçi, I., & Henein, M. Y. (2019) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12595 · Cited by 59
Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy
Bassiouny, M., Lindsay, B. D., Lever, H. M., Saliba, W. I., Klein, A. L., Banna, M., Abraham, J. M., Shao, M., Rickard, J., Kanj, M. H., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.042 · Cited by 58
Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis
Masri, A., Kanj, M. H., Thamilarasan, M., Wazni, O. M., Smedira, N. G., Lever, H. M., & Desai, M. Y. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2016.11.23 · Cited by 57
Hypertrophic cardiomyopathy
Antunes, M. D. O., & Scudeler, T. L. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100503 · Cited by 53
Research priorities in sarcomeric cardiomyopathies
van der Velden, J., Ho, C. Y., Tardiff, J. C., Olivotto, I., Knollmann, B. C., & Carrier, L. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv019 · Cited by 53
Self-citation
Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease
Maron, B. J., & Braunwald, E. (2012) · Circulation · doi:10.1161/circulationaha.112.123174 · Cited by 50
Long‐Term Results of Transcatheter Atrial Fibrillation Ablation in Patients with Impaired Left Ventricular Systolic Function
Anselmino, M., Grossi, S., Scaglione, M., Castagno, D., BIANCHI, F., SENATORE, G., Matta, M., Casolati, D., Ferraris, F., Cristoforetti, Y., et al. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02419.x · Cited by 50
Self-citation
Is Pursuit of Termination of Atrial Fibrillation During Catheter Ablation of Great Value in Patients with Longstanding Persistent Atrial Fibrillation?
PARK, Y. M., Choi, J., Lim, H. E., Park, S. W., & Kim, Y. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02370.x · Cited by 47
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome
Dinshaw, L., Münkler, P., Schäffer, B., Klatt, N., Jungen, C., Dickow, J., Tamenang, A., Schleberger, R., Pecha, S., Pinnschmidt, H. O., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.017451 · Cited by 48
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study
Creta, A., Elliot, P. M., Earley, M. J., Dhinoja, M., Finlay, M., Sporton, S. C., CHOW, A. W. C., Hunter, R. J., Παπαγεωργίου, Ν., LOWE, M. D., et al. (2021) · EP Europace · doi:10.1093/europace/euab022 · Cited by 43
Atrial Fibrillation in Hypertrophic Cardiomyopathy
Vaidya, K., Semsarian, C., & Chan, K. H. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.116 · Cited by 40
Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
Boll, G., Rowin, E. J., Maron, B. J., Wang, W., Rastegar, H., & Maron, M. S. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.09.029 · Cited by 40
Atrial fibrillation in patients with inherited cardiomyopathies
Yeung, C., Enriquez, A. A., Suarez‐Fuster, L., & Baranchuk, A. M. (2018) · EP Europace · doi:10.1093/europace/euy064 · Cited by 37
Ablation of Typical Right Atrial Flutter in Patients with Pulmonary Hypertension
Luesebrink, U., Fischer, D., Gezgin, F., Duncker, D., König, T., Oswald, H., Klein, G. G., & Gardiwal, A. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.06.005 · Cited by 36
Catheter ablation of atrial fibrillation in chronic heart failure: state-of-the-art and future perspectives
Anselmino, M., Matta, M., Castagno, D., Giustetto, C., & Gaïta, F. (2016) · EP Europace · doi:10.1093/europace/euv368 · Cited by 34
Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Rozen, G., Elbaz‐Greener, G., Marai, I., Andria, N., Hosseini, S. M., Biton, Y., Heist, E. K., Ruskin, J. N., Gavrilov, Y., Carasso, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015721 · Cited by 35
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Bongini, C., Ferrantini, C., Girolami, F., Coppini, R., Arretini, A., Targetti, M., Bardi, S., Castelli, G., Torricelli, F., Cecchi, F., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.058 · Cited by 34
Self-citation
Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation
Angel, N. A., Li, L., MacLeod, R., MARROUCHE, N. F., Ranjan, R., & Dosdall, D. J. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12773 · Cited by 33
Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
Hayashi, H., Hayashi, M., Miyauchi, Y., Takahashi, K., Uetake, S., Tsuboi, I., Yodogawa, K., Iwasaki, Y., & Shimizu, W. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9894-y · Cited by 33
Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†
Lapenna, E., Pozzoli, A., Bonis, M. D., Canna, G. L., Nisi, T., Nascimbene, S., Vicentini, L., Sanzo, S. D., Forno, B. D., Schiavi, D., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx017 · Cited by 32
Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review
Moore, J. C., Trager, L. E., Anzia, L. E., Saliba, W. I., Bassiouny, M., Bhargava, M., Chung, M. K., Desai, M. Y., Garberich, R., Lever, H. M., et al. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13310 · Cited by 31
Impact of Left Ventricular Diastolic Dysfunction on Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Okamatsu, H., Ohara, T., Kanzaki, H., Nakajima, I., Miyamoto, K., Okamura, H., Noda, T., Aiba, T., KUSANO, K. F., Kamakura, S., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0823 · Cited by 29
Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long‐term results and clinical outcomes
Castagno, D., Donna, P. D., Olivotto, I., Frontera, A., Calò, L., Scaglione, M., Arretini, A., Anselmino, M., Giustetto, C., Ferrari, G. M. D., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14880 · Cited by 26
Self-citation
Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease
Efremidis, M., Bazoukis, G., Vlachos, K. G., Prappa, E., Anastasakis, A., Megarisiotou, A., Dragasis, S., Asvestas, D., Mililis, P., Saplaouras, A., et al. (2021) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2021.06.001 · Cited by 25
The development of familial hypertrophic cardiomyopathy: from mutation to bedside
Brouwer, W. P., van Dijk, S. J., Stienen, G. J. M., van Rossum, A. C., van der Velden, J., & Germans, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02439.x · Cited by 25
Atrial and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Kumar, K. R., Mandleywala, S. N., & Link, M. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.002 · Cited by 26
Atrial fibrillation in hypertrophic cardiomyopathy: pathophysiology, diagnosis and management.
Falasconi, G., Pannone, L., Slavich, M., Margonato, A., Fragasso, G., & Spoladore, R. (2020) · PubMed Central · Cited by 23
Thoracic Surgeons Society for Cardiovascular Angiography and Interventions, and Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, of Thoracic Surgery, American Society of Echocardiography, American Society Developed in Collaboration With the American Association for Guidelines Cardiology Foundation/American Heart Association Task Force on Practice Cardiomyopathy: Executive Summary: A Report of the American College of 2011 ACCF/AHA Guideline for the Diagnosis…
Yancy, C. W., Seidman, C. E., Towbin, J. A., Udelson, J. E., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Gersh, J. K., Maron, B. J., Bonow, R. O., et al. (2012) · Cited by 21
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review
Ha, H. S. K., Wang, N., Wong, S., Phan, S., Liao, J., Kumar, N., Qian, P. C., Yan, T. D., & Phan, K. H. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0047-8 · Cited by 21
Thromboembolism in Patients with Hypertrophic Cardiomyopathy
Liu, L., Liu, Z., Chen, X., & He, S. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.50167 · Cited by 20
Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: A proportional meta-analysis and systematic review of single-arm studies
Latif, A., Ahmad, S., Ahsan, M. J., Willman, C., Lateef, N., Kapoor, V., Ikram, S., Ahsan, M. Z., Meyers, J. D., & Kim, M. H. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.01.002 · Cited by 20
Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy
Yadav, S. K., & Szczesna‐Cordary, D. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0248-8 · Cited by 20
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko, P., Polańska, M., Chojnowska, L., Michałowska, I. M., Wójcik, A., Piotrowicz, E., Lech, A., Kłopotowski, M. M., Baranowski, R., Przybylski, A., et al. (2013) · PubMed · Cited by 20
Long‐Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy
Roh, S., Kim, D., Ahn, J., Lee, K., Lee, D. I., Shim, J., Choi, J., PARK, S., & Kim, Y. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12985 · Cited by 19
Long‐term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy
Chen, X., Dong, J., Du, X., Wu, J., Yu, R., Long, D., Ning, M., Sang, C., Jiang, C., Bai, R., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13645 · Cited by 19
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy
Haq, I.-U., Akhiyat, N., Al-Shakarchi, N. J., Siontis, K. C., Mulpuru, S. K., Sugrue, A. M., Giudicessi, J. R., Friedman, P. A., Asirvatham, S. J., & Killu, A. M. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.03.026 · Cited by 18
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
Palyam, V., Azam, A. T., Odeyinka, O., Alhashimi, R., Thoota, S., Ashok, T., & Sange, I. (2022) · Cureus · doi:10.7759/cureus.21101 · Cited by 18
Adaptive frequency tracking of the baseline ECG identifies the site of atrial fibrillation termination by catheter ablation
Buttu, A., Pruvot, E. J., Zaen, J. V., Viso, A., Forclaz, A., Pascale, P., Narayan, S. M., & Vésin, J.-M. (2013) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2013.02.005 · Cited by 18
Five‐year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
Zheng, S., Jiang, W., Dai, J., Li, K., Shi, H., Wu, W., Liu, X., He, B., Qiu, X., & Song, Z. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14349 · Cited by 18
A Primer on Arrhythmias in Patients with Hypertrophic Cardiomyopathy
Bockstall, K. E., & Link, M. S. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0297-3 · Cited by 17
Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach
Hodges, K., Tang, A., Rivas, C. A. G., Umana-Pizano, J. B., Chemtob, R. A., Desai, M. Y., Gillinov, A. M., Smedira, N. G., & Wierup, P. N. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14946 · Cited by 17
Results of catheter ablation of atrial fibrillation in hypertrophied hearts – Comparison between primary and secondary hypertrophy
Müssigbrodt, A., Kosiuk, J., Koutalas, E. P., Pastromas, S., Dagres, N., Darma, A., Lucas, J., Breithardt, O. A., Sommer, P., Dinov, B., et al. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.07.005 · Cited by 16
Targeted Medical Therapies for Hypertrophic Cardiomyopathy
Fumagalli, C., Gregorio, M. G. D., Zampieri, M., Fedele, E., Tomberli, A., Chiriatti, C., Marchi, A., & Olivotto, I. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-1258-x · Cited by 15
Self-citation
Association Between Success Rate and Citation Count of Studies of Radiofrequency Catheter Ablation for Atrial Fibrillation
Perino, A. C., Hoang, D. D., Holmes, T. H., Santangeli, P., Heidenreich, P. A., Perez, M. V., Wang, P. J., & Turakhia, M. P. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.000912 · Cited by 16
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication
Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Battistoni, A., Gallo, G., Barbato, E., Spera, F. R., & Magrì, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020501 · Cited by 14
The Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (MAGIC‐AF) Study: Clinical Background and Study Design
Singh, S. M., d’Ávila, A., Kim, Y., Aryana, A., Mangrum, J. M., Michaud, G. F., Dukkipati, S. R., Callans, D. J., Barrett, C. D., Jovine, M., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02198.x · Cited by 14
QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Wen, S., Liu, N., Li, S., Wu, X., Salim, M., Kang, J.-P., Ning, M., Wu, J., Ruan, Y., Yu, R., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1290 · Cited by 13
Catheter ablation for atrial fibrillation: current patient selection and outcomes
Walsh, K., & Marchlinski, F. E. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1510317 · Cited by 13
Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project
Perego, G. B., Iacopino, S., Molon, G., Arena, G., Verlato, R., Pieragnoli, P., Curnis, A., Allocca, G., Nicolis, D., Sciarra, L., et al. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.02.015 · Cited by 12
Conduction velocity is reduced in the posterior wall of hypertrophic cardiomyopathy patients with normal bipolar voltage undergoing ablation for paroxysmal atrial fibrillation
Zahid, S., Malik, T., Peterson, C., Tarabanis, C., Dai, M. S., Katz, M., Bernstein, S., Barbhaiya, C. R., Park, D. S., Knotts, R. J., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01533-9 · Cited by 11
Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.001 · Cited by 10
Self-citation
Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure
Anselmino, M., Matta, M., Bunch, T. J., Fiala, M., Scaglione, M., Nölker, G., Qian, P. C., Neumann, T., Ferraris, F., & Gaïta, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.067 · Cited by 10
Self-citation
Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
Lin, C., Lin, C.-Y., Chung, F., Lin, Y., Chang, S., Lo, L., Hu, Y., Chao, T., Liao, J., Chang, T., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1135230 · Cited by 9
Epidemiology of Heart Failure
Dahlström, U. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_1 · Cited by 8
Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
Ikenaga, H., Nakano, Y., Oda, N., Suenari, K., Sairaku, A., Tokuyama, T., Kawazoe, H., Matsumura, H., Tomomori, S., & Kihara, Y. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.08.006 · Cited by 8
Respiratory syncytial virus-associated mortality in a healthy 3-year-old child: a case report
Gavotto, A., Ousselin, A., Pidoux, O., Cathala, P., Costes‐Martineau, V., Rivière, B., Pasquié, J., Amédro, P., Rambaud, C., & Cambonie, G. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1847-2 · Cited by 8
of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society American Association for Thoracic Surgery, American Society of Foundation/American Heart Association Task Force on Practice Guidelines Cardiomyopathy: A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic
Towbin, J. A., Udelson, J. E., Nishimura, R. A., Ommen, S. R., Rakowski, H., Bonow, R. O., Dearani, J. A., Fifer, M. A., Gersh, B. J., & Maron, B. J. (2011) · Cited by 7
Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy
Wen, S., Zhu, H., Sun, P., Wu, K., Liu, N., Ruan, Y., Bai, R., Tang, R., Yu, R., Long, D., et al. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14137 · Cited by 7
Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases
Mohmand-Borkowski, A., & Tang, W. H. W. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9424-0 · Cited by 6
Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series
Maagh, P., Plehn, G., Christoph, A., Örnek, A., & Meißner, A. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.16181 · Cited by 6
The Challenge of Pregnancy in Women With Hypertrophic Cardiomyopathy
Lloji, A., & Panza, J. A. (2021) · Cardiology in Review · doi:10.1097/crd.0000000000000394 · Cited by 6
Catheter Ablation for Atrial Fibrillation in Structural Heart Disease: A Review
Brasca, F. M. A., Menè, R., & Perego, G. B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041431 · Cited by 6
Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
Zhang, H., Ding, L., Weng, S.-X., Zhou, B., Ding, X., Hu, L., Qi, Y., Yu, F., Feng, T., Zhang, J.-T., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.766571 · Cited by 6

Authors: Di Donna, P., Olivotto, I., Delcre, S. D. L., Caponi, D., Scaglione, M., Nault, I., Montefusco, A., Girolami, F., Cecchi, F., Haissaguerre, M., & Gaita, F.
Affiliations: Azienda Ospedaliero-Universitaria Careggi (IT)
University of Turin (IT)
Hôpital Cardiologique du Haut-Lévêque (FR)
ORCID: Olivotto, I.
Scaglione, M.
Nault, I.
Montefusco, A.
Girolami, F.
Cecchi, F.
Venue: Europace
Publisher: Oxford University Press (OUP)
Published: 2010-02-20
Volume: 12
Issue: 3
Pages: 347-355
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/euq013
OpenAlex: W2171261466
Cited by: 138
References: 28
Citations by year: 2026: 1 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 8 · 2014: 18 · 2013: 10 · 2012: 12
FWCI: 7.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Florence Research (University of Florence) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: European Commission (241577)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: hypertrophic cardiomyopathy, atrial fibrillation, radiofrequency catheter ablation, pulmonary vein isolation, atrial remodeling, left atrial volume, NYHA functional class, age, disease progression, arrhythmia recurrence, repeat ablation, genotypes, MYBPC3, MYH7, myosin light chain 2, antiarrhythmic therapy, predictors of treatment outcome, sinus rhythm
MeSH terms: Adult, Age Factors, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Combined Modality Therapy, Female, Follow-Up Studies, Genetic Testing, Genotype, Heart Atria, Humans, Male, Middle Aged, Predictive Value of Tests, Echocardiography, Doppler, Treatment Outcome, Catheter Ablation, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks